CNB Bank’s Zymeworks ZYME Stock Holding History

CNB Bank’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-775	Closed	-$37K	–	442
2020 Q4	$37K	Hold	775	–	–	0.03%	242
2020 Q3	$36K	Hold	775	–	–	0.03%	232
2020 Q2	$28K	Buy	775 +425	+121%	+$15.7K	0.02%	254
2020 Q1	$12K	Hold	350	–	–	0.01%	290
2019 Q4	$16K	Buy	+350	New	+$12.7K	0.01%	297

Other funds holding ZYME

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CNB Bank's ZYME Position: Q1 2021 in Review

CNB Bank sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 775 shares — an estimated $37K sold.

CNB Bank first reported a position in ZYME in Q4 2019 and held it in 5 quarters. The position peaked at $37K in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

CNB Bank reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
CNB Bank sold 775 Zymeworks shares in Q1 2021, an estimated $37K.
CNB Bank first reported a position in Zymeworks in Q4 2019 and held it in 5 quarters.
CNB Bank's Zymeworks position peaked at $37K in Q4 2020.
125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on CNB Bank's 13F filing for Q1 2021, filed 3 May 2021.